BESPOKE BIOLOGIX Trademark

Trademark Overview

On Wednesday, August 23, 2023, a trademark application was filed for BESPOKE BIOLOGIX with the United States Patent and Trademark Office. The USPTO has given the BESPOKE BIOLOGIX trademark a serial number of 98146695. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Monday, August 25, 2025. This trademark is owned by QC Holdings LLC. The BESPOKE BIOLOGIX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Regenerative medicine services
bespoke biologix

General Information

Serial Number98146695
Word MarkBESPOKE BIOLOGIX
Filing DateWednesday, August 23, 2023
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateMonday, August 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements

Goods and ServicesRegenerative medicine services
NOT AVAILABLE"BIOLOGICS"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 24, 2023
Primary Code044
First Use Anywhere DateWednesday, August 23, 2023
First Use In Commerce DateSaturday, February 1, 2025

Trademark Owner History

Party NameQC Holdings LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCharlotte, NC 28202
Party NameQC Holdings LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCharlotte, NC 28202

Trademark Events

Event DateEvent Description
Saturday, August 26, 2023NEW APPLICATION ENTERED
Sunday, September 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 8, 2024ASSIGNED TO EXAMINER
Tuesday, February 13, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 13, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, February 13, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 13, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, February 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 25, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 23, 2025USE AMENDMENT FILED
Wednesday, April 23, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, June 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 4, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 4, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2024SOU EXTENSION 1 GRANTED
Friday, October 25, 2024SOU EXTENSION 1 FILED
Friday, August 22, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, August 25, 2025NON-FINAL ACTION E-MAILED
Monday, August 25, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 25, 2025SU - NON-FINAL ACTION - WRITTEN

Related Keywords

biologix bespoke services medicine regenerative